Suppr超能文献

经皮腔内血管成形术与肾血管重建手术的对比分析。

Comparative analysis of percutaneous transluminal angioplasty and operation for renal revascularization.

作者信息

Erdoes L S, Berman S S, Hunter G C, Mills J L

机构信息

Department of Surgery, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA.

出版信息

Am J Kidney Dis. 1996 Apr;27(4):496-503. doi: 10.1016/s0272-6386(96)90159-6.

Abstract

Contemporary patients requiring renal revascularization often have diffuse atherosclerosis, and increasingly undergo intervention for salvage of renal function rather than control of hypertension alone. Risk-benefit analyses and outcome data are difficult to obtain, since few reports have analyzed a modern, unselected series of consecutive patients subjected to renal revascularization by surgical as well as interventional techniques. We reviewed our 5-year experience with 76 consecutive renal revascularizations in 63 patients. Indications for intervention were hypertension and renal salvage, 60 percent (n = 38); hypertension, 24 percent (n = 15); renal salvage, 9.5 percent (n = 6); and other, 6.5 percent (n = 4). Ninety-four percent (n = 59) of patients had atherosclerotic occlusive disease of the renal arteries. Percutaneous transluminal angioplasty (PTA) was initially performed on 18 renal arteries in 16 patients, of whom 56 percent (n = 9) subsequently required surgical reconstruction. Fifty-eight surgical reconstructions were performed in 56 patients and consisted of aortorenal bypass (n = 27), aortorenal endarterectomy (n = 18), and extra-anatomic bypass (n = 13). Concomitant aortic replacement was required in 57 percent (n = 32) of patients. Preoperative risk factors and operative indications did not differ between the PTA and surgical reconstruction groups. Morbidity and mortality rates associated with PTA were 33 percent and 4.8 percent, respectively, while for surgical treatment the morbidity rate was 7 percent and the mortality rate 5.3 percent (P = NS). Functional improvement was achieved in 74 percent of surgically treated patients compared with 22 percent of PTA-treated patients (P < 0.01). Actuarial renal artery primary patency at 48 months was 81 percent for the surgery group and 17 percent for the PTA group (P < 0.01). Aortorenal bypass, endarterectomy, and extra-anatomic bypass were equally efficacious (P > 0.05). The results of surgical reconstruction are excellent, offering more durable patency and functional improvement than PTA, without increased risk. The operation should be tailored to fit the individual patient's disease, since the results of endarterectomy and bypass procedures are equivalent.

摘要

当代需要进行肾血管重建的患者往往患有弥漫性动脉粥样硬化,而且越来越多地是为了挽救肾功能而非单纯控制高血压而接受干预治疗。由于很少有报告分析过一系列采用手术及介入技术对未经选择的连续患者进行肾血管重建的现代情况,因此难以获得风险效益分析及结果数据。我们回顾了63例患者连续76次肾血管重建的5年经验。干预指征为高血压和挽救肾功能,占60%(n = 38);高血压,占24%(n = 15);挽救肾功能,占9.5%(n = 6);其他,占6.5%(n = 4)。94%(n = 59)的患者患有肾动脉粥样硬化闭塞性疾病。最初对16例患者的18条肾动脉进行了经皮腔内血管成形术(PTA),其中56%(n = 9)的患者随后需要进行手术重建。对56例患者进行了58次手术重建,包括主动脉 - 肾动脉旁路移植术(n = 27)、主动脉 - 肾动脉内膜切除术(n = 18)和解剖外旁路移植术(n = 13)。57%(n = 32)的患者需要同时进行主动脉置换。PTA组和手术重建组术前危险因素及手术指征无差异。PTA相关的发病率和死亡率分别为33%和4.8%,而手术治疗的发病率为7%,死亡率为5.3%(P = 无显著性差异)。手术治疗的患者中有74%实现了功能改善,而PTA治疗的患者中这一比例为22%(P < 0.01)。手术组48个月时肾动脉初始通畅率的精算值为81%,PTA组为17%(P < 0.01)。主动脉 - 肾动脉旁路移植术、内膜切除术和解剖外旁路移植术疗效相当(P > 0.05)。手术重建的结果非常好,与PTA相比,能提供更持久的通畅率和功能改善,且风险未增加。手术应根据个体患者的病情进行调整,因为内膜切除术和旁路手术的结果是等效的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验